The efficacy and safety of photoselective vaporization of the prostate with a potassium-titanyl-phosphate laser for symptomatic benign prostatic hyperplasia according to prostate size: 2-year surgical outcomes

Korean Journal of Urology

Volumn 51, Issue 5, 2010, Pages 330-336

  Kim, Hyung Suk ^a   Cho, Min Chul ^a   Ku, Ja Hyeon ^a   Kim, Soo Woong ^a   Paick, Jae Seung ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Laser therapy; Potassium titanylphosphate; Prostatic hyperplasia

Indexed keywords

CREATININE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER NECK CONTRACTURE; CLINICAL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DYSURIA; FOLLOW UP; HEMATURIA; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LASER; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; POSTVOID RESIDUAL URINE VOLUME; POTASSIUM TITANYL PHOSPHATE LASER; PREOPERATIVE EVALUATION; PROSTATE HYPERTROPHY; PROSTATE SURGERY; RETROGRADE EJACULATION; RETROSPECTIVE STUDY; SURGEON; TRANSRECTAL ULTRASONOGRAPHY; TRANSURETHRAL ELECTROVAPORIZATION; URETHRA STRICTURE; URGE INCONTINENCE; UROFLOWMETRY;

EID: 77952776314     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2010.51.5.330     Document Type: Article

References (19)

1. Lee E, Yoo KY, Kim Y, Shin Y, Lee C. Prevalence of lower urinary tract symptoms in Korean men in a community-based study. Eur Urol 1998;33:17-21. (Pubitemid 28033412)
2. Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 2004;46:547-554 (Pubitemid 39345720)
3. Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Henderson WG. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 1995;332:75-79
4. Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol 2006;50:969-979
5. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 2004;172:1404-1408
6. Bachmann A, Schürch L, Ruszat R, Wyler SF, Seifert HH, Müller A, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005;48:965-971
7. Spaliviero M, Araki M, Page JB, Wong C. Catheter-free 120W lithium triborate (LBO) laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). Lasers Surg Med 2008;40:529-534
8. McAllister WJ, Gilling PJ. Vaporization of the prostate. Curr Opin Urol 2004;14:31-34
9. Choo SH, Han DH, Lee SW. The efficacy and safety of KTP photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: the 2-year results. Korean J Urol 2008;49:831-836
10. Margel D, Lifshitz D, Brown N, Lask D, Livne PM, Tal R. Predictors of nocturia quality of life before and shortly after prostatectomy. Urology 2007;70:493-497 (Pubitemid 47464507)
11. Monoski MA, Gonzalez RR, Sandhu JS, Reddy B, Te AE. Urodynamic predictors of outcomes with photoselective laser vaporization prostatectomy in patients with benign prostatic hyperplasia and preoperative retention. Urology 2006;68:312-317 (Pubitemid 44175484)
12. Hwang CH, Cho CK, Lee YK, Hong SJ. Comparative analysis of short-term efficacy and complication of photoselective vaporization for benign prostatic hyperplasia which was classified by prostate size. Korean J Urol 2007;48:826-831
13. Lee J, Kang SH, Kim JJ. Evaluation of the quality of life and the efficacy of treatment after high power potassium-titanyl-phosphate (KTP) laser vaporization for patients with a prostate volume greater than 40 cc. Korean J Urol 2007;48:956-964 (Pubitemid 47496988)
14. Malek RS, Kuntzman RS, Barrett DM. Photoselective potassium-titanyl- phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 2005;174:1344-1348
15. Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005;173:158-160 (Pubitemid 39627700)
16. Horasanli K, Silay MS, Altay B, Tanriverdi O, Sarica K, Miroglu C. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial. Urology 2008;71:247-251 (Pubitemid 351282348)
17. Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 2004;64:1155-1159 (Pubitemid 39647058)
18. Ruszat R, Seitz M, Wyler SF, Abe C, Rieken M, Reich O, et al. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 2008;54:893-901.
19. Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. Eur Urol 2006;50:969-979